Biography of Jeffrey Albers

Last update: November 28, 2023

Career

Jeffrey was Chief Executive Officer at Blueprint Medicines, and Board Member at Kymera Therapeutics. Jeffrey Albers joined Spyre Therapeutics in 2023.

Jeffrey Albers is currently Director at Spyre Therapeutics - View - Spyre Therapeutics org chart

Create your alert
to follow the career of Jeffrey Albers.

Education

Jeffrey Albers has a Master of Business Administration from Georgetown University McDonough School of Business.

They have also studied at Georgetown University McDonough School of Business :

Find more alumni from Georgetown University McDonough School of Business

More about Jeffrey Albers

The colleagues of Jeffrey Albers

Company Colleagues
Industry Colleagues
  • In the Biotechnology industry, Jeffrey Albers has 30,266 colleagues in 2,283 companies located in 40 countries. 14,433 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Jeffrey Albers.

Get in Touch

Sorry, but Jeffrey Albers cannot be contacted yet through our email service. Please use our Premium/VIP service to join colleagues of Jeffrey Albers listed below. Here are a few tips for establishing great contacts.

With Skype, Call Spyre Therapeutics at +1 512... and ask for Jeffrey Albers.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.